FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589988471> ?p ?o ?g. }

• W2589988471 abstract "Abstract Abstract 4143 Introduction: The use of vitamins and dietary supplements is a common health practice in many parts of the world, in part because of the belief that they will prevent diseases, including cancer. However, results of epidemiologic studies regarding their efficacy in reducing the risk of any cancer, particularly hematologic malignancies, are inconsistent and are mostly limited to case-control studies. Materials: Participants were male and female members of the VITamins And Lifestyle (VITAL) cohort. Between 2000 and 2002, 64,839 men and women, aged 50 to 76 years, who lived in the region of Washington State covered by the Surveillance, Epidemiology, and End Results (SEER) registry, were recruited. Participants were excluded if they had any cancer prior to baseline other than non-melanoma skin cancer and were censored at the time of diagnosis of a non-hematologic malignancy during follow-up; after exclusions, there were 64,839 participants available for study. Incident cases of hematologic malignancies were identified through December 2008 by linkage to the SEER registry. Participants answered questions on the frequency (days/week), duration (years), and dose per day of their supplemental use of vitamins, including A, B3, B6, B12, C, D, E, multivitamin compounds, and folic acid; minerals, including calcium, selenium, iron, magnesium, chrome, and zinc during the 10 years before baseline. For the non-vitamin, non-mineral “specialty” supplements, garlic, ginseng, and fish oil, only frequency and duration were ascertained. Use of vitamin and mineral supplements was categorized into non-users and tertiles of use, such that the highest category was greater than could be achieved only by use of a common multivitamin (Centrum Silver). 10-year average use of specialty supplements was categorized into: non-user; low use, <4 days/week or <3 years; and high use, ≥4 days/week and ≥3 years. Multivariable-adjusted Cox proportional hazards models were used to estimate hazards ratios (HR) and 95% confidence intervals (95% CI) of the use of dietary supplements with the risk of total hematologic malignancies. Models were adjusted for age, sex, race/ethnicity (white/hispanic/other), education, smoking, self-rated health, physical activity, history of anemia in the year before baseline, and family history of leukemia or lymphoma. Results: A total of 577 case of hematological malignancies were identified including MDS [n=54], AML [n=36], myeloproliferative disorders [n=46], CLL/SLL [n=88] and other non-Hodgkin lymphomas [n=235], Hodgkin lymphomas [n=22], plasma cell disorders [n=66], mature NK/T cell neoplasms [n=17], and other entities [n=13]). None of the vitamin 10-year average intakes were associated with decreased risk of incident hematologic malignancies There was no evidence that high use of vitamins A (HR=0.79, 95% CI: 0.58–1.08; p-trend=0.28), B12 (HR=0.98, 95%CI: 0.73–1.31; p-trend=0.26), C (HR=0.97, 95% CI: 0.77–1.22; p-trend=0.99), D (HR=0.90, 95% CI: 0.62–1.31; p-trend=0.45), or folic acid (HR=1.00, 95% CI: 0.73–1.39; p-trend=0.19) was associated with the risk of blood cancer. Among specialty supplements, only high 10-year average use of garlic was significantly associated with a reduced risk of development of blood cancers (HR=0.64,95% CI: 0.42–0.98); however the association was not linear (p-trend=0.14). Conclusions: We observed no reduction in the risk of incident hematologic malignancies with dietary supplement and vitamin use with the exception of garlic when used at a high amount (≥4 days/week for ≥ 3 years). Disclosures: No relevant conflicts of interest to declare." @default.
• W2589988471 created "2017-03-03" @default.
• W2589988471 creator A5000172773 @default.
• W2589988471 creator A5013626352 @default.
• W2589988471 creator A5055685996 @default.
• W2589988471 creator A5075165389 @default.
• W2589988471 date "2010-11-19" @default.
• W2589988471 modified "2023-10-01" @default.
• W2589988471 title "Vitamins, Minerals, and Specialty Supplements and Risk of Hematological Malignancies In the VITamins and Lifestyle (VITAL) Cohort Study" @default.
• W2589988471 doi "https://doi.org/10.1182/blood.v116.21.4143.4143" @default.
• W2589988471 hasPublicationYear "2010" @default.
• W2589988471 type Work @default.
• W2589988471 sameAs 2589988471 @default.
• W2589988471 citedByCount "0" @default.
• W2589988471 crossrefType "journal-article" @default.
• W2589988471 hasAuthorship W2589988471A5000172773 @default.
• W2589988471 hasAuthorship W2589988471A5013626352 @default.
• W2589988471 hasAuthorship W2589988471A5055685996 @default.
• W2589988471 hasAuthorship W2589988471A5075165389 @default.
• W2589988471 hasConcept C107130276 @default.
• W2589988471 hasConcept C121608353 @default.
• W2589988471 hasConcept C126322002 @default.
• W2589988471 hasConcept C142724271 @default.
• W2589988471 hasConcept C14522933 @default.
• W2589988471 hasConcept C201903717 @default.
• W2589988471 hasConcept C2776551950 @default.
• W2589988471 hasConcept C2776940978 @default.
• W2589988471 hasConcept C2778527826 @default.
• W2589988471 hasConcept C2780234812 @default.
• W2589988471 hasConcept C71924100 @default.
• W2589988471 hasConcept C72563966 @default.
• W2589988471 hasConcept C99454951 @default.
• W2589988471 hasConceptScore W2589988471C107130276 @default.
• W2589988471 hasConceptScore W2589988471C121608353 @default.
• W2589988471 hasConceptScore W2589988471C126322002 @default.
• W2589988471 hasConceptScore W2589988471C142724271 @default.
• W2589988471 hasConceptScore W2589988471C14522933 @default.
• W2589988471 hasConceptScore W2589988471C201903717 @default.
• W2589988471 hasConceptScore W2589988471C2776551950 @default.
• W2589988471 hasConceptScore W2589988471C2776940978 @default.
• W2589988471 hasConceptScore W2589988471C2778527826 @default.
• W2589988471 hasConceptScore W2589988471C2780234812 @default.
• W2589988471 hasConceptScore W2589988471C71924100 @default.
• W2589988471 hasConceptScore W2589988471C72563966 @default.
• W2589988471 hasConceptScore W2589988471C99454951 @default.
• W2589988471 hasLocation W25899884711 @default.
• W2589988471 hasOpenAccess W2589988471 @default.
• W2589988471 hasPrimaryLocation W25899884711 @default.
• W2589988471 hasRelatedWork W1560131859 @default.
• W2589988471 hasRelatedWork W1940848234 @default.
• W2589988471 hasRelatedWork W1991475177 @default.
• W2589988471 hasRelatedWork W2005967825 @default.
• W2589988471 hasRelatedWork W2069400347 @default.
• W2589988471 hasRelatedWork W2090464171 @default.
• W2589988471 hasRelatedWork W2119962948 @default.
• W2589988471 hasRelatedWork W2122485053 @default.
• W2589988471 hasRelatedWork W2133826872 @default.
• W2589988471 hasRelatedWork W2144035768 @default.
• W2589988471 hasRelatedWork W2147778732 @default.
• W2589988471 hasRelatedWork W2172021299 @default.
• W2589988471 hasRelatedWork W2283195443 @default.
• W2589988471 hasRelatedWork W2316002280 @default.
• W2589988471 hasRelatedWork W2333193585 @default.
• W2589988471 hasRelatedWork W2588126043 @default.
• W2589988471 hasRelatedWork W2803745859 @default.
• W2589988471 hasRelatedWork W2871826268 @default.
• W2589988471 hasRelatedWork W3005083169 @default.
• W2589988471 hasRelatedWork W3203519431 @default.
• W2589988471 isParatext "false" @default.
• W2589988471 isRetracted "false" @default.
• W2589988471 magId "2589988471" @default.
• W2589988471 workType "article" @default.